<table border="0" cellpadding="3" id="t27440522" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2 Effect of Coadministered Drugs on Systemic Exposure
of Linagliptin</caption>
<colgroup>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
</colgroup>
<tfoot>
<tr>
<td colspan="5">*Multiple dose (steady state) unless otherwise noted<br/>
<sup>#</sup>Single dose<br/>
<sup>†</sup>AUC = AUC(0 to 24 hours) for single dose treatments
and AUC = AUC(TAU) for multiple dose treatments<br/>QD = once
daily<br/>BID = twice daily<br/>TID = three times daily</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" rowspan="2" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Coadministered Drug</content>
</content>
</td>
<td align="center" rowspan="2" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Dosing of Coadministered Drug*</content>
</content>
</td>
<td align="center" rowspan="2" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Dosing of Linagliptin*</content>
</content>
</td>
<td align="center" colspan="2" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">
<content stylecode="emphasis">Geometric Mean Ratio<br/>(ratio with/without coadministered
drug)<br/>No effect = 1.0</content>
</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">AUC<sup>†</sup>
</td>
<td stylecode="Toprule Lrule Rrule Botrule">Cmax</td>
</tr>
<tr>
<td colspan="5" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">No dosing
adjustments required for TRADJENTA when given with the following coadministered
drugs:</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">Metformin</td>
<td stylecode="Toprule Lrule Rrule Botrule">850 mg TID</td>
<td stylecode="Toprule Lrule Rrule Botrule">10 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.20</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.03</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">Glyburide</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.75 mg<sup>#</sup>
</td>
<td stylecode="Toprule Lrule Rrule Botrule">5 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.02</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.01</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">Pioglitazone</td>
<td stylecode="Toprule Lrule Rrule Botrule">45 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">10 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.13</td>
<td stylecode="Toprule Lrule Rrule Botrule">1.07</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">Ritonavir</td>
<td stylecode="Toprule Lrule Rrule Botrule">200 mg BID</td>
<td stylecode="Toprule Lrule Rrule Botrule">5 mg<sup>#</sup>
</td>
<td stylecode="Toprule Lrule Rrule Botrule">2.01</td>
<td stylecode="Toprule Lrule Rrule Botrule">2.96</td>
</tr>
<tr>
<td colspan="5" stylecode="Toprule Lrule Rrule Botrule">
<content stylecode="bold">The efficacy
of TRADJENTA may be reduced when administered in combination with
strong inducers of CYP3A4 or P-gp (e.g., rifampin). Use of alternative
treatments is strongly recommended <content stylecode="italics">[see Drug Interactions
(<linkhtml href="#Section_7.1">7.1</linkhtml>)]</content>.</content>
</td>
</tr>
<tr>
<td stylecode="Toprule Lrule Rrule Botrule">Rifampin</td>
<td stylecode="Toprule Lrule Rrule Botrule">600 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">5 mg QD</td>
<td stylecode="Toprule Lrule Rrule Botrule">0.60</td>
<td stylecode="Toprule Lrule Rrule Botrule">0.56</td>
</tr>
</tbody>
</table>